CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
scanning a/LCIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03502798
NCT03502798N/ACompleted
CompareCT.gov

Coherence Imaging of the Cervical Epithelium With Scanning a/LCI

Duke University·interventional·Posted Apr 19, 2018·Updated Feb 18, 2021

In Brief

A clinical study evaluating scanning a/LCI for Cervical Dysplasia. Completed, enrolled 45 participants across 2 sites.

Detailed Summary

The purpose of this study is to develop a low coherence interferometry (LCI) endoscopic probe that can examine the cervix for evidence of cervical dysplasia. The device will make optical measurements of the cervix to determine: 1. the difference between two different types of cervical cells: ectocervical cells and endocervical cells. Cervical dysplasia is most likely to occur at the junction between these two types of cells. 2. features of individual cervical cells that indicate whether the cell is normal or abnormal (cervical dysplasia).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Dysplasia
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Jacobi Medical Center

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 19, 2018
Enrollment StartNov 8, 2018
Primary CompletionFeb 14, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.2 years ago

Interventions

scanning a/LCIdevice

Imaging of the cervical epithelium using the scanning a/LCI device.